Outcomes from treatment of metastatic renal-cell carcinoma following failure of first-line anti-VEGF/VEGFR therapy: real-life evidence on the change of the treatment paradigm-MedSci.cn

Outcomes from treatment of metastatic renal-cell carcinoma following failure of first-line anti-VEGF/VEGFR therapy: real-life evidence on the change of the treatment paradigm

Bamias, A; Zakopoulou, R; Tzannis, K; Sakellakis, M; Koutsoukos, K; Kyriazoglou, A; Panagiotou, A; Armylagos, S; Rokas, K; Gotzias, D; Boulouta, A; Bozionelou, V; Stravodimos, K; Varkarakis, I; Mavroudis, D; Dimopoulos, MA

Bamias, A (通讯作者)，ATTIKON Univ Hosp, Propaedeut Dept Internal Med 2, 1 Rimini St, Chaidari 12462, Greece.

Abstract

Recently approved agents for post-vascular endothelial growth factor/post-vascular endothelial growth factor receptor (VEGF/VEGFR) inhibitors treatmen......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Outcomes from treatment of metastatic renal-cell carcinoma following failure of first-line anti-VEGF/VEGFR therapy: real-life evidence on the change of the treatment paradigm

科室

工具

服务